Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Astellas Pharma Co. Ltd, 5 Waterside, Citywest Business Campus, Naas Road, Dublin 24, Ireland
Nivadil 16mg Prolonged release capsules.
| Pharmaceutical Form |
|---|
|
Prolonged release capsule, hard. (Prolonged release capsule) Hard gelatin capsules with an opaque brown cap (overprinted with “NV16” in white) and an opaque brown/red body containing yellow round pellets. |
Each capsule contains Nilvadipine 16.0 mg.
For the full list of excipents, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nilvadipine |
Nilvadipine at very low concentrations inhibits the influx of calcium into the cell of the smooth vascular musculature and thereby cause vasodilatation. The myogenic vascular-wall tonus is reduced and the peripheral vascular resistance diminished. This in turn results in an antihypertensive effect. |
| List of Excipients |
|---|
|
Contents of capsule: Maize starch Capsule shell: Iron oxides (E172) Printing ink: Shellac |
Nature: Blister made of PVC/PVDC Film on aluminium foil (250 mm coated with 40 g/m PVDC; 20 mm Al).
Package sizes: Original packages containing: 28 prolonged release capsules
Astellas Pharma Co. Ltd, 5 Waterside, Citywest Business Campus, Naas Road, Dublin 24, Ireland
PA 1241/13/2
Date of first authorisation: 22nd July 1996
Date of last renewal: 22nd July 2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
